125 results
Page 5 of 7
10-K
EX-10.1
urrft
16 Mar 20
Annual report
11:09am
8-K
EX-99.1
m3vhh 8i2sfje9p078z8
7 Nov 19
Regulation FD Disclosure
4:01pm
8-K
yvs7ruo
31 Oct 19
Entry into a Material Definitive Agreement
4:46pm
DEF 14A
1eg5chmh
1 Oct 19
Definitive proxy
6:07am
8-K
EX-10.1
k1on4gv8gm3w2k4n
27 Sep 19
Arcturus Therapeutics Announces $9.8 Million Registered Direct Offering of Common Stock
4:25pm
8-K
EX-1.1
e05r3v
27 Sep 19
Arcturus Therapeutics Announces $9.8 Million Registered Direct Offering of Common Stock
4:25pm
424B5
qjo7obv
27 Sep 19
Prospectus supplement for primary offering
4:14pm
8-K
tdacvov2w5sun70ndso
23 Sep 19
Arcturus Therapeutics Announces Appointment of Dr. Edward Holmes M.D. andRe-Appointment of Andy Sassine to the Board of Directors
4:34pm
8-K
EX-10.1
5d019
5 Aug 19
Arcturus Therapeutics Announces $2.3 Million Additional Registered Direct Offering of Common Stock
9:14am
424B5
ukqqzx
5 Aug 19
Prospectus supplement for primary offering
9:08am
8-K
EX-10.1
z9blvo7laip2uuac
2 Aug 19
Arcturus Therapeutics Announces $10.9 Million Registered Direct Offering of Common Stock
4:29pm
8-K
EX-1.1
zz67103n970gp4
2 Aug 19
Arcturus Therapeutics Announces $10.9 Million Registered Direct Offering of Common Stock
4:29pm
424B5
xnn0c
2 Aug 19
Prospectus supplement for primary offering
4:28pm